Diabetes
Testing
Centers™
with Chronic Care Programs
Our Solutions.
Your Legacy.
Diabetes
Testing
Centers™
with Chronic Care Programs
Our Solutions.
Your Legacy.
The first year after a major diabetes-related complication is the most dangerous — and the most preventable. First-year mortality rates reach:
Up to 50% for Alzheimer's.
Up to 40% for Amputations.
Up to 30% for CHF/Strokes.
They're not statistics, they're loved ones.
Find what others miss
Diabetes Testing Centers™ (DTC) was founded by former family practice owners shaped by firsthand experience with late detection and preventable complications in everyday care. That perspective was further informed by enterprise healthcare management leadership in diagnostics and diabetes, guiding DTC’s development of scalable, non-invasive, reimbursable point-of-care programs. Today, with a national network of more than 20,000 independent practices, DTC helps CMS-ready and Cash-ready providers identify patient risks within the same visit.
Three Areas Where Early Detection Changes Everything
Neuropathy. Early nerve damage often goes unnoticed until pain, ulceration, or amputation risk appears. DTC programs identify small and large fiber loss early, allowing intervention before irreversible damage occurs.
Cardiovascular. Diabetes quietly accelerates vascular disease long before symptoms appear. DTC programs help surface cardiovascular risk earlier, supporting prevention of CHF, stroke, and limb loss.
Cognitive. Metabolic dysfunction and diabetes are increasingly linked to cognitive decline. DTC programs help identify early cognitive risk, enabling earlier intervention when outcomes are still modifiable.
DTC equips medical organizations with validated assessments, operational support, and program infrastructure to deliver complete, condition-specific care pathways.
Designed to Help:
• Screen for risks earlier
• Test non-invasively
• Treat through care pathways
Organizations Achieve:
• Predictable revenue per patient visit
• Evidence-based early detection
• Turnkey chronic care programs
DTC delivers the clinical science behind 25 Chronic Care Programs trusted by specialists nationwide. Clinics can onboard flexibly, integrate seamlessly into existing workflows, and begin generating recurring revenue in under 30 days.*
Pick A pathway
Turnkey Programs, No New Tools
DTC helps clinics activate comprehensive clinical pathways that integrate seamlessly with the diagnostic tools you already use—supporting insurance, cash, or hybrid models while enabling clear medical necessity and effective patient treatment.
Early Detection Gives Families More Time and Memories to Share.
Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable. DTC transforms routine exams—including Annual Wellness Visits—into advanced preventive care encounters by combining reimbursable diagnostics, state-of-the-art early-detection technology, and chronic-care pathways that ensure compliance and payment integrity.
Our exclusive 25 Chronic Care Programs are designed for primary care and multispecialty settings and chronic patients. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver CMS-ready and Cash-ready programs—many of which do not require new staff, new construction, or disruption to your workflow.
By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.
Get Reimbursed for DPN and More
Following National Guidelines
National guidelines recommend that primary care physicians, endocrinologists, podiatrists, and neuropathy specialists screen all diabetic patients for neuropathy at least once a year. Neuropathy is one of the earliest and most common complications of diabetes, and its detection has important clinical implications.
Small fiber neuropathy is often the first sign of metabolic dysfunction or poorly controlled diabetes, serving as an early warning that systemic complications may be developing.
Large fiber neuropathy, on the other hand, is closely tied to loss of protective sensation—leading to falls, infections, wounds, and ultimately amputations and inspected at every visit once identified.
When neuropathy is detected, it not only signals nerve damage but also indicates an elevated risk of other serious diabetes-related complications such as cardiovascular disease, renal decline, and vision loss, all of which share the same underlying metabolic origin. When you can Screen, Test and Treat in-house and remotely, you not only keep patients under your care, you break the chain reaction at its source. That’s what makes our 25 Chronic Care Programs more than just assessments, they are the bridge between routine care and long-term health.
Neuropathy is a serious condition that, if not accurately diagnosed and treated promptly, can lead to devastating outcomes, such as amputations of the toes, feet, or legs. The failure to adopt advanced diagnostic tools and procedures has resulted in medical institutions and physicians being held liable for malpractice. A landmark case, Washington v. Washington Hospital (1990)., set legal precedent in the U.S. regarding this issue.
About 80% of 65+ have two or more chronic conditions.
Most diabetic and chronic patients don't always see the specialists who could detect early complications because referrals are delayed, so the urgency is slowed and the disease progresses silently. The difference isn’t necessarily the visit itself—it’s the results of the diagnostic tests that help determine the plan of care for the patients. Traditional screening tools in PCP clinics are often outdated, limited in what they detect and non-reimbursable (e.g. monofilaments). DTC brings modern, clinically validated, reimbursable diagnostics into a practice, enabling primary care and multispecialty clinics to identify risks earlier and keep care in-house—before referrals are needed. Better detection. Better outcomes. Better Revenue.
Our Chronic Care Programs give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams. Instead of relying on outdated tools (e.g., fishing string for foot exams), replace them with modern, non-invasive diagnostic devices that are reimbursable and fit directly into existing workflows. The visit stays the same—the tools simply get better, the data becomes clearer, and the clinic is reimbursed for the care it is already providing.
Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike.
Our turnkey programs make it possible to intervene earlier with rapid, non-invasive, point-of-care tests such as neuropathy testing, PAD screening, cognitive assessments, and cardiovascular risk evaluations. Each fits seamlessly into your workflow, enabling your team to detect risks, initiate treatment plans, and manage progression both in-clinic and remotely. The result is better outcomes for patients, stronger trust in your care, and new reimbursable revenue streams that support practice growth.
Primary Care & Multispecialty
Pain & Neurology
Endocrinology & Metabolism
Why Offer In-House Specialty Testing
Most diabetic patients never see the specialists who could detect early complications—referrals are delayed, visits are missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are.
State-of-the-Art Diagnostics
Primary Care Providers (PCP) check patients blood glucose but why stop there? With in-clinic neuropathy, cognitive, or vascular testing, you can diagnose earlier, act sooner, and keep care under your roof instead of waiting on outside referrals. This means you’re not just monitoring—you’re diagnosing, acting sooner, and keeping patients under your care with clinically valuable results that directly improve outcomes.
Getting Started Is Simple:
Think about the top three patient referrals your clinic makes, like labs, neurology, podiatry, endocrinology, cardiology, physical therapy, or others. This helps you determine which patients have unmet needs that your clinic may fulfill.
Review our Chronic Care Programs® and pick one that aligns with the referrals you make. For example, if you refer patients to neurology, choose our neuropathy testing program. If you refer to cardiology, consider our cardiovascular risk evaluation, etc.
Select a program with a zero-down option to begin testing these patients immediately in your clinic, without any upfront investment and get a financial pro forma from us based on your location and payor reimbursements. This allows you to start providing and billing for these services, regularly in 30 days or less.
Bring Early Detection In-Clinic
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.